This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

NANT Cancer Vaccine / Cancer BioShield

NANT Cancer Vaccine / Cancer BioShield is a investigational cancer vaccine and immune-platform concept associated with combination immunotherapy, tumor antigen presentation, immune activation, and personalized or platform-based cancer treatment strategies. In cancer care, it should be evaluated by evidence level, intended use, safety, interactions, and whether it is being used as conventional treatment, supportive care, an experimental adjunct.

Doctors

Dr. Patrick Soon-Shiong

doctor, surgeon | Abraxis BioScience, ANKTIVA, Cancer MoonShot 2020 / Cancer Breakthroughs 2020, Chan Soon-Shiong Family Foundation, Chan Soon-Shiong Institute for Medicine, Chan Soon-Shiong Institute of Molecular Medicine, ImmunityBio, Los Angeles Times, NantHealth, NantKwest, NantOmics, NantWorks

South African-born American surgeon, billionaire biotech entrepreneur, inventor of Abraxane, founder/executive of Immunity Bio/Nant companies, and developer/promoter of ANKTIVA/NANT Cancer Vaccine immunotherapy platforms. Patrick Soon-Shiong is a physician and biotechnology entrepreneur associated with cancer immunotherapy, including immune activation and natural killer cell-related approaches. Patrick Soon-Shiong, M. D.
WebsiteWikipedia
All Protocols